Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Óvári Krisztián László

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2023-2025

2025

Erdődi, B., Jakab, A., Óvári, K., Tarczali, Á., Krasznai, Z. T., Kozma, B.: Papillary projections in differentiating benign, borderline, and malignant ovarian tumours: a retrospective quantitative ultrasonographic study.
Ultrasound in Obstetrics & Gynecology 66 (S1), 99, 2025.

doi DEA

2024

Óvári, K., Szentei, J., Tarczali, A., Bozsa, S., Krasznai, Z. T., Jakab, A., Erdődi, B.: Increasing number of borderline ovarian tumours: do we have an effective tool to diagnose them preoperatively?.
Ultrasound Obstet. Gynecol. 64 (Suppl.), 340, 2024.

doi DEA

Erdődi, B., Tarczali, A., Szentei, J., Óvári, K., Szőllősi, G. J., Bozsa, S., Krasznai, Z. T., Jakab, A.: Ultrasound characteristics of borderline ovarian tumours selected by ADNEX model.
Ultrasound Obstet. Gynecol. 64 (S1), 331-332, 2024.

DEA

2023

Szántó, G. T., Fehér, Á., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K., Lányi, Á., Panyi, G., Varga, Z.: 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel.
Pharmaceuticals (Basel). 16 (5), 1-15, (article identifier: 656), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science